华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03320 华润医药

休市中 08-14 16:08:36

4.845

-0.045

-0.92%

最高4.915	最低4.815	成交量375.28万
今开4.890	昨收4.890	日振幅2.05%
总市值304.41亿	流通市值304.39亿	总股本62.83亿
成交额1,818万	换手率0.06%	流通股本62.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.845,"timestamp":1786694916007,"preClose":4.89,"halted":0,"volume":3752750,"delay":0,"changeRate":-0.009202453987730048,"floatShares":6282510461,"shares":6283000000,"eps":0.7485671393023897,"marketStatus":"休市中","change":-0.045,"latestTime":"08-14 16:08:36","open":4.89,"high":4.915,"low":4.815,"amount":18181706,"amplitude":0.02045,"askPrice":4.845,"askSize":13000,"bidPrice":4.835,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":0.7485671393023897,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":7,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.89,"dividendRate":0.044954,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":0.5476815153865898,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"2658516941","title":"华润医药(03320.HK)拟8月24日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2658516941","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658516941?lang=zh_cn&edition=full","pubTime":"2026-08-12 07:07","pubTimestamp":1786489621,"startTime":"0","endTime":"0","summary":"格隆汇8月12日丨华润医药(03320.HK)发布公告，公司将于2026年8月24日(星期一)举行董事会会议，旨在(其中包括)考虑及通过(如适用)(i)公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布；以及(ii)宣派中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260812/32332178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1570","BK1191","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141946961","title":"华润医药（03320）拟于8月24日召开董事会 审议2026年中期业绩及股息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1141946961","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141946961?lang=zh_cn&edition=full","pubTime":"2026-08-12 06:10","pubTimestamp":1786486227,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司（03320）12日公告，公司董事会会议拟定于2026年8月24日（星期一）举行，届时将审议和通过（如适用）：\\n\\n1. 公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布；\\n\\n2. 宣派中期股息（如有）。\\n\\n公告显示，当前董事会成员包括执行董事、非执行董事及独立非执行董事共12人，董事会主席为白晓松。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184840683","title":"华润医药7月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1184840683","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184840683?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:38","pubTimestamp":1785749931,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司于2026年8月3日披露的截至2026年7月31日止月份证券变动月报表显示，公司(股票代码：03320)在报告期内并无新增发行、购回、注销或库存股份的变动。截至7月末，公司已发行股份总数维持6,282,510,461股，与上月底一致。\n根据公告，公司已满足适用的公众持股量要求。此外，公司于2017年12月12日获股东大会通过股份期权计划，月末可供行使的股份总数为628,450,646股，但报告期内并无实际行权或新增发行。\n公告由公司秘书温詠宜呈交，公司同时明确表明持续遵守香港联合交易所有限公司上市规则及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655810620","title":"华润医药(03320.HK)附属华润双鹤拟56.56亿元收购利尔化学约23.5%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2655810620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655810620?lang=zh_cn&edition=full","pubTime":"2026-07-30 06:49","pubTimestamp":1785365363,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1570","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153015038","title":"华润医药56.56亿元拟入主利尔化学 成其最大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=1153015038","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153015038?lang=zh_cn&edition=full","pubTime":"2026-07-30 06:11","pubTimestamp":1785363061,"startTime":"0","endTime":"0","summary":"2026年7月30日，华润医药集团有限公司公告称，其非全资附属公司华润双鹤药业股份有限公司已于2026年7月29日与四川久远投資控股集團有限公司及四川化材科技有限公司签订《股权收购协议》，拟以每股30.07元人民币收购利尔化学股份有限公司共计188,102,749股股份，占其已发行股份的23.50%，交易总对价人民币5,656,249,662.43元，折合56.56亿元。交易完成后，华润双鹤将持有利尔化学23.50%股权并成为其最大股东，利尔化学将被纳入华润医药合并报表范围的非全资附属公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886476","title":"华润医药：附属公司完成发行10亿元中期票据，票面年利率1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886476","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655886476?lang=zh_cn&edition=full","pubTime":"2026-07-29 19:01","pubTimestamp":1785322860,"startTime":"0","endTime":"0","summary":"7月29日，华润医药（03320）发布公告，全资附属公司华润医药控股有限公司完成发行第二期2026年中期票据，本金额为10亿元，期限3年，票面年利率为1.52%。公告指出，发行中期票据所得募集资金净额将用于偿还有息债务及其他符合适用法律法规的用途。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607293825238696.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607293825238696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","03320","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113694030","title":"华润医药(03320)发行10亿元第二期2026年中期票据，票面利率1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113694030","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113694030?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:41","pubTimestamp":1785321666,"startTime":"0","endTime":"0","summary":"7月29日，华润医药集团有限公司（03320）公告称，其全资附属公司华润医药控股有限公司已在中国完成发行本金金额人民币10亿元的“第二期2026年中期票据”。\n本期中期票据期限为三年，票面年利率1.52%，所募资金净额将用于偿还有息债务及其他符合法律法规的用途。\n华润医药表示，发行人此前已于5月29日和7月22日发布相关拟发行公告及首期中期票据发行信息。本次为2026年中期票据的第二期，进一步完善了公司多元化融资渠道。\n公司提醒投资者在买卖公司证券时保持审慎。\n截至公告日，董事会成员包括执行董事兼主席白晓松，以及程杰、刘长安等。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655869731","title":"华润医药(03320.HK)完成发行10亿元第二期2026年中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2655869731","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655869731?lang=zh_cn&edition=full","pubTime":"2026-07-29 18:38","pubTimestamp":1785321531,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03320","BK1191","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653759599","title":"华润医药(03320)完成发行第一期2026年中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2653759599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653759599?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:03","pubTimestamp":1784714626,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，于2026年7月21日，本公司的全资附属公司华润医药控股有限公司(华润医药控股)已于中国完成发行第一期2026年中期票据(第一期2026年中期票据)。本金额人民币10亿元的第一期2026年中期票据已发行，期限三年，票面年利率为1.53%。发行第一期2026年中期票据所得募集资金将用于补充营运资金、偿还有息债务及其他合符适用法例法规的用途。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03320","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653759518","title":"华润医药(03320.HK)完成发行第一期2026年中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2653759518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653759518?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:03","pubTimestamp":1784714626,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651584492","title":"【券商聚焦】光大证券：议优先布局经营稳健、业绩扎实或者股息类中药标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2651584492","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651584492?lang=zh_cn&edition=full","pubTime":"2026-07-16 08:54","pubTimestamp":1784163265,"startTime":"0","endTime":"0","summary":"金吾财讯 | 光大证券研究指，近期，中药板块持续上涨，主要受到市场避险、政策利好、业绩催化和估值底部等多重因素共同推动，中期配置价值显著，后市偏乐观。建议优先布局经营稳健、业绩扎实或者高股息类中药标的。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjJmNDVlM2IxNTc1MzAyMDFjYTFhODQyNzEzMTQ0NzU5OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985990","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","00874","BK0028","02161","BK1606","601788","BK4588","03613","BK1147","06178","02877","KCE","VIG","BK1191","03320","BK1564","01643","BK1197","BK0183","BK1515","00570","BK1521","02273","BK0188","BK4585","BK1570","BK0012","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651046137","title":"华润医药(03320.HK)附属华润双鹤可能收购利尔化学部分股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2651046137","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651046137?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:18","pubTimestamp":1784125098,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","BK1191","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169720927","title":"华润医药（03320）获确认为利尔化学23.50%股权首位意向受让方","url":"https://stock-news.laohu8.com/highlight/detail?id=1169720927","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169720927?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:15","pubTimestamp":1784124944,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司7月15日公告，其间接非全资附属公司华润双鹤药业股份有限公司已参与由四川久远投资控股集团有限公司及四川化材科技有限公司通过公开征集转让方式出售的利尔化学股份有限公司股份项目，并被确认为排名第一的意向受让方。\\n\\n 根据公告，待转让股份为188,102,749股，约占利尔化学已发行股本的23.50%。目前，华润双鹤并未持有利尔化学任何股权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167711416","title":"华润医药旗下双鹤药业于2026年7月15日竞购利尔化学股份中拔得头筹","url":"https://stock-news.laohu8.com/highlight/detail?id=1167711416","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167711416?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:15","pubTimestamp":1784124918,"startTime":"0","endTime":"0","summary":"在2026年7月15日进行的一场股权竞购中，华润医药集团旗下的双鹤药业成功脱颖而出，在针对利尔化学股份的竞标中位列第一。这一进展标志着华润医药在拓展其产业布局方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651461696","title":"华润医药：拟收购利尔化学约23.50%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651461696","media":"南方财经网","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651461696?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:13","pubTimestamp":1784124780,"startTime":"0","endTime":"0","summary":"南财智讯7月15日电，华润医药（03320.HK）发布内幕消息公告，公司间接非全资附属公司华润双鹤药业股份有限公司已参与由四川久远投资控股集团有限公司及四川化材科技有限公司发起的公开征集转让方式，拟受让其合计持有的利尔化学股份有限公司（股票代码：002258）18810.27万股股份，占利尔化学股权约23.50%。截至公告日，华润双鹤未持有利尔化学任何股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807789855.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807789855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0122","03320","002258","BK0028","BK0229","BK0201","BK1570","BK0186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132969918","title":"华润医药披露天士力医药2026年上半年业绩：归母净利8.93亿元，同比增15.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132969918","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132969918?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:40","pubTimestamp":1784029250,"startTime":"0","endTime":"0","summary":"2026年7月14日，华润医药公告披露，其通过非全资子公司华润三九医药股份有限公司持股约28%的天士力医药集团股份有限公司公布了截至2026年6月30日止六个月的未经审计初步财务数据。天士力医药在报告期内实现营业总收入42.01亿元，同比下降2.03%；实现营业利润10.48亿元，同比增长14.87%；利润总额10.46亿元，同比增长15.67%。华润医药提醒，以上数据基于中国公认会计准则编制且未经审计，相关最终财务信息以天士力医药即将发布的2026年中期报告为准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651108544","title":"华润医药(03320)：天士力医药上半年归母净利润为8.93亿元，同比增长15.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651108544","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651108544?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:40","pubTimestamp":1784029209,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布，于2026年上半年，天士力医药实现营业总收入人民币42.01亿元(同比下跌2.03%，主要由于中药注射剂行业整体下滑，以及感冒发烧药物的销售收入较去年同期减少)，上市公司股东应占净利润人民币8.93亿元，同比增长15.23%;上市公司股东应占净利润(扣除非经常性损益)人民币8.71亿元，同比增长36.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600535","09939","159938","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651108348","title":"华润医药(03320.HK)：华润三九上半年实现归母净利润16.72亿元 同比下降7.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651108348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651108348?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:37","pubTimestamp":1784029063,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178819480","title":"华润医药(03320)：控股子公司华润三九2026年上半年收入150.13亿元，同比增长1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178819480","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178819480?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:35","pubTimestamp":1784028949,"startTime":"0","endTime":"0","summary":"2026年7月14日，华润医药公告称，其控股63.22%的子公司华润三九医药股份有限公司披露了截至2026年6月30日止六个月的未经审计初步财务数据。华润三九在报告期内实现营业总收入150.13亿元，同比增加1.37%；实现营业利润24.98亿元，同比下降4.67%；利润总额25.34亿元，同比下降3.48%。截至2026年6月30日，华润三九总资产为558.57亿元，较期初减少5.01%；上市公司股东应占权益为228.74亿元，较期初增长3.17%；每股净资产13.74元，较期初增长3.15%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651174363","title":"华润医药(03320.HK)：昆药集团预计中期归母净亏损为3.3亿元至4亿元  同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2651174363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651174363?lang=zh_cn&edition=full","pubTime":"2026-07-14 18:06","pubTimestamp":1784023560,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1570","03320"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0442},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0832},{"period":"1year","weight":-0.0354},{"period":"ytd","weight":0.122}],"compareEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.0177},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0546},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家主要从事医药业务的投资控股公司。该公司通过四个分部运营业务。制药业务分部研发、制造及销售一系列药品及保健品。药品分销业务分部向医院、分销商及零售药店等药品制造商、器械制造商及配药商提供分销、仓储、物流及其他药品供应链增值解决方案及相关服务。药品零售业务分部经营零售药店。其他业务营运分部从事持有物业及其他业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.012765},{"month":2,"riseRate":0.7,"avgChangeRate":0.045371},{"month":3,"riseRate":0.5,"avgChangeRate":0.003211},{"month":4,"riseRate":0.7,"avgChangeRate":0.030284},{"month":5,"riseRate":0.5,"avgChangeRate":0.000669},{"month":6,"riseRate":0.3,"avgChangeRate":-0.002129},{"month":7,"riseRate":0.3,"avgChangeRate":-0.023835},{"month":8,"riseRate":0.4,"avgChangeRate":-0.001995},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.02076},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.027129},{"month":11,"riseRate":0.4,"avgChangeRate":0.010245},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000965}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}